Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of SH-03 for diabetic neuropathic pain in adults with type 2 diabetes
MOH_2021-01-07_009651Phase 2Not yet recruiting
- Sponsor
- Seach Medical Group
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic neuropathy comparing SH-03 with Placebo (2 arms). Primary endpoint: Safety and efficacy of SH-03. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
cannabidiol + tetrahydrocannabinol
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on MOH_2021-01-07_009651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-01-07_009651.